Hopen Life Science Ventures is a Grand Rapids, Michigan–based venture capital firm founded in the mid-2000s that focuses on early- to mid-stage investments in innovative life science and healthcare companies in the United States, particularly in medical devices, diagnostics, therapeutics, healthcare IT and related sectors. The firm seeks to partner with founders and management teams bringing research-driven technologies to market, often providing strategic capital alongside industry expertise to help companies advance through clinical, regulatory and commercial milestones. Hopen has historically concentrated investment activity in the Midwest while participating in broader syndicates with co-investors and has backed companies that have later raised significant follow-on capital or achieved acquisitions. Its investment approach blends financial support with networks of scientific and operational advisors to help portfolio firms scale and address systemic healthcare challenges. Hopen Life Science Ventures manages multiple funds that have targeted early and expansion stages, engaging with healthcare innovation in the U.S. venture ecosystem.